Table 3.
Body composition was measured at baseline, at the end of phase 1, and at the end of phase 2 with the bioimpedance method
| Parameter | Whole sample (N = 36) |
Subsample (N = 18) |
||
|---|---|---|---|---|
| Baseline | End phase 1 | End phase 1 | End phase 2 | |
| Weight (kg) | 70.8 (51.4–132.1) | 68.2 (48.2–119.1)*** | 66.4 (48.2–104.9) | 63.4 (46.5–101.9)** |
| Body fat (%) | 30.3 ± 10.1 | 26.3 ± 8*** | 26.5 ± 6.4 | 24.6 ± 5.5* |
| Visceral fat (arbitrary units) | 5.5 (1–20) | 4 (1–16)*** | 4 (1–16) | 4 (1–15)* |
| BMI (kg/m2) | 26.5 (19.1–48.5) | 25.2 (17.9–42.2)*** | 24.7 (17.9–34.4) | 23.4 (17.3–31.7)** |
| Muscle mass (kg) | 48.8 (37.1–86.5) | 48.7 (37.1–84.1)* | 46.7 (37.1–77.9) | 46.7 (38.6–75.3) |
| Total body water (L) | 50.4 ± 6.4 | 53.1 ± 5.9*** | 52.7 ± 4.8 | 53.7 ± 4.1 |
*
P < 0.05 compared with the previous study time point;
**
P < 0.01 compared with the previous study time point;
***
P < 0.001 compared with the previous study time point. Data are shown as mean ± standard deviation for normally distributed variables and as median (minimum–maximum) for non-normally distributed ones.